Elamipretide Recruiting Phase 3 Trials for Age - Related Macular Degeneration (AMD) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Recruiting | Treatment | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT06373731 | ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) |